|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-5-13
|
|
pubmed:abstractText |
Schizophrenic patients treated with atypical antipsychotics (AAPs) often develop excessive body weight gain (BWG), which may lead to further morbidity and poor treatment compliance. This study examined whether genetic variants in the dopamine receptor D2 (DRD2) gene may be associated with body weight change after AAP treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1744-6880
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
359-66
|
|
pubmed:meshHeading |
pubmed-meshheading:20375926-Adult,
pubmed-meshheading:20375926-Antipsychotic Agents,
pubmed-meshheading:20375926-Benzodiazepines,
pubmed-meshheading:20375926-Body Weight,
pubmed-meshheading:20375926-Clozapine,
pubmed-meshheading:20375926-Female,
pubmed-meshheading:20375926-Genes,
pubmed-meshheading:20375926-Genotype,
pubmed-meshheading:20375926-Haplotypes,
pubmed-meshheading:20375926-Humans,
pubmed-meshheading:20375926-Long-Term Care,
pubmed-meshheading:20375926-Male,
pubmed-meshheading:20375926-Middle Aged,
pubmed-meshheading:20375926-Odds Ratio,
pubmed-meshheading:20375926-Receptors, Dopamine D2,
pubmed-meshheading:20375926-Risperidone,
pubmed-meshheading:20375926-Schizophrenia,
pubmed-meshheading:20375926-Weight Gain
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.
|
|
pubmed:affiliation |
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan. cjhong@vghtpe.gov.tw
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
